11 November 2023: Clinical Research
Comparative Analysis of Symptomatology in Hospitalized Children with RSV, COVID-19, and Influenza Infections
Weronika M. Balas 1BCDEF , Andrzej Śliwczyński 2CDE , Paweł Olszewski 3ACDE , Izabela Gołębiak 3CDE , Adam J. Sybilski 14ACDEF*DOI: 10.12659/MSM.941229
Med Sci Monit 2023; 29:e941229
Table 2 Occurrence of symptoms depending on the age of the child diagnosis (OR; [95%CI]) – in bold statistically significant values.
| 0–6 months of age | 7–24 months of age | >24 months of age | |
|---|---|---|---|
| Number of patients with COVID-19 | 0.77 [0.3–1.94] | 1 | 0.33 [0.1–1.16] |
| Number of patients with RSV | 1.55 [0.65–3.65] | 1 | 0.15 [0.05–0.47] |
| Number of patients with influenza | 0.58 [0.144–2.32] | 1 | |
| Dyspnoea in RSV | 1 | 0.1875 [0.02–1.98] | |
| Duration of fever in RSV [≥2 days vs | 0.26 [0.03–1.96] | 2.57 [0.34–19.33] | 1 |
| Elevated CRP concentration in RSV [≥10 mg/l vs | 1 | 1.45 [0.41–5.07] |